{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T00:16:06Z","timestamp":1791332166460,"version":"4.3.1"},"reference-count":80,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["aacejournalendocrinepractice.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Endocrine Practice"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.4158\/ep-2019-0363","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T10:41:27Z","timestamp":1580899287000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":91,"title":["TSH Receptor Antibodies: Relevance & Utility"],"prefix":"10.1016","volume":"26","author":[{"given":"George J.","family":"Kahaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul D.","family":"Olivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4158\/EP-2019-0363_bb0010","first-page":"1343","volume":"26","author":"Ross","year":"2016","journal-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis"},{"key":"10.4158\/EP-2019-0363_bb0015","first-page":"167","volume":"7","author":"Kahaly","year":"2018","journal-title":"2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism"},{"key":"10.4158\/EP-2019-0363_bb0020","first-page":"585","volume":"21","author":"Kahaly","year":"2011","journal-title":"The American Thyroid Association\/American Association of Clinical Endocrinologists guidelines for hyperthyroidism and other causes of thyrotoxicosis: a European perspective"},{"key":"10.4158\/EP-2019-0363_bb0025","first-page":"28","volume":"8","author":"Kahaly","year":"2017","journal-title":"TSH receptor antibody functionality and nomenclature"},{"issue":"4S suppl 1","key":"10.4158\/EP-2019-0363_bb0030","first-page":"S13","volume":"34","author":"Diana","year":"2018","journal-title":"Thyroid stimulating hormone receptor antibodies in thyroid eye disease-methodology and clinical applications"},{"key":"10.4158\/EP-2019-0363_bb0035","first-page":"853","volume":"50","author":"Diana","year":"2018","journal-title":"Thyrotropin receptor blocking antibodies"},{"key":"10.4158\/EP-2019-0363_bb0040","first-page":"184","volume":"376","author":"Kahaly","year":"2017","journal-title":"Graves' disease"},{"key":"10.4158\/EP-2019-0363_bb0045","first-page":"1648","volume":"99","author":"Diana","year":"2014","journal-title":"Clinical relevance of thyroid-stimulating autoantibodies in pediatric Graves' disease: a multicenter study"},{"key":"10.4158\/EP-2019-0363_bb0050","first-page":"1103","volume":"17","author":"Smith","year":"2007","journal-title":"Persistence of thyrotropin (TSH) receptor antibodies in children and adolescents with Graves' disease treated using antithyroid medication"},{"key":"10.4158\/EP-2019-0363_bb0055","first-page":"62","volume":"51","author":"Sto\u017cek","year":"2018","journal-title":"Functional TSH receptor antibodies in children with autoimmune thyroid diseases"},{"key":"10.4158\/EP-2019-0363_bb0060","first-page":"734","volume":"26","author":"Diana","year":"2016","journal-title":"Analytical performance and validation of a bioassay for thyroid-blocking antibodies"},{"key":"10.4158\/EP-2019-0363_bb0065","first-page":"304","volume":"189","author":"Diana","year":"2017","journal-title":"Prevalence and clinical relevance of thyroid stimulating hormone receptor-blocking antibodies in autoimmune thyroid disease"},{"key":"10.4158\/EP-2019-0363_bb0070","first-page":"5537","volume":"151","author":"Morshed","year":"2010","journal-title":"Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades"},{"key":"10.4158\/EP-2019-0363_bb0075","first-page":"17","volume":"47","author":"Morshed","year":"2013","journal-title":"How one TSH receptor antibody induces thyrocyte proliferation while another induces apoptosis"},{"key":"10.4158\/EP-2019-0363_bb0080","first-page":"1675","volume":"337","author":"Paschke","year":"1997","journal-title":"The thyrotropin receptor in thyroid diseases"},{"key":"10.4158\/EP-2019-0363_bb0085","first-page":"161","volume":"110","author":"Davies","year":"2002","journal-title":"The TSH receptor reveals itself"},{"key":"10.4158\/EP-2019-0363_bb0090","first-page":"726","volume":"362","author":"Bahn","year":"2010","journal-title":"Graves' ophthalmopathy"},{"key":"10.4158\/EP-2019-0363_bb0095","first-page":"116","volume":"10","author":"Lytton","year":"2010","journal-title":"Bioassays for TSH-receptor autoantibodies: an update"},{"key":"10.4158\/EP-2019-0363_bb0100","first-page":"13733","volume":"269","author":"Allgeier","year":"1994","journal-title":"The human thyrotropin receptor activates G-proteins Gs and Gq\/11"},{"key":"10.4158\/EP-2019-0363_bb0105","first-page":"109","volume":"147","author":"Holzapfel","year":"2002","journal-title":"Expression of G(alpha)(s) proteins and TSH receptor signalling in hyper-functioning thyroid nodules with TSH receptor mutations"},{"key":"10.4158\/EP-2019-0363_bb0110","first-page":"319","volume":"38","author":"Latif","year":"2009","journal-title":"The thyroid-stimulating hormone receptor: impact of thyroid-stimulating hormone and thyroid-stimulating hormone receptor antibodies on multimerization, cleavage, and signaling"},{"key":"10.4158\/EP-2019-0363_bb0115","first-page":"923","volume":"17","author":"Smith","year":"2007","journal-title":"TSH receptor antibodies"},{"key":"10.4158\/EP-2019-0363_bb0120","first-page":"566","volume":"71","author":"Schott","year":"2009","journal-title":"Clinical value of the first automated TSH receptor autoantibody assay for the diagnosis of Graves' disease (GD): an international multicentre trial"},{"key":"10.4158\/EP-2019-0363_bb0125","first-page":"107","volume":"12","author":"Tozzoli","year":"2012","journal-title":"TSH receptor autoantibody immunoassay in patients with Graves' disease: improvement of diagnostic accuracy over different generations of methods. Systematic review and meta-analysis"},{"key":"10.4158\/EP-2019-0363_bb0130","first-page":"880","volume":"47","author":"Frank","year":"2015","journal-title":"Bridge technology with TSH receptor chimera for sensitive direct detection of TSH receptor antibodies causing Graves' disease: analytical and clinical evaluation"},{"key":"10.4158\/EP-2019-0363_bb0135","first-page":"438","volume":"162","author":"Lytton","year":"2010","journal-title":"Novel chimeric thyroid-stimulating hormone-receptor bioassay for thyroid-stimulating immunoglobulins"},{"key":"10.4158\/EP-2019-0363_bb0140","first-page":"612","volume":"132","author":"Botero","year":"1998","journal-title":"Bioassay of thyrotropin receptor antibodies with Chinese hamster ovary cells transfected with recombinant human thyrotropin receptor: clinical utility in children and adolescents with Graves disease"},{"key":"10.4158\/EP-2019-0363_bb0145","first-page":"251","volume":"67","author":"Tokuda","year":"1988","journal-title":"Inhibition of thyrotropin-stimulated iodide uptake in FRTL-5 thyroid cells by crude immunoglobulin fractions from patients with goitrous and atrophic autoimmune thyroiditis"},{"key":"10.4158\/EP-2019-0363_bb0150","first-page":"809","volume":"17","author":"Chiovato","year":"1994","journal-title":"Detection of antibodies blocking thyrotropin effect using Chinese hamster ovary cells transfected with the cloned human TSH receptor"},{"key":"10.4158\/EP-2019-0363_bb0155","first-page":"577","volume":"49","author":"Watson","year":"1998","journal-title":"A new chemiluminescent assay for the rapid detection of thyroid stimulating antibodies in Graves' disease"},{"key":"10.4158\/EP-2019-0363_bb0160","first-page":"374","volume":"84","author":"Evans","year":"1999","journal-title":"Development of a luminescent bioassay for thyroid stimulating antibodies"},{"key":"10.4158\/EP-2019-0363_bb0165","first-page":"355","volume":"54","author":"Jordan","year":"2001","journal-title":"A luminescent bioassay for thyroid blocking antibodies"},{"key":"10.4158\/EP-2019-0363_bb0170","first-page":"3","volume":"4","author":"Kahaly","year":"2015","journal-title":"Bioassays for TSH receptor antibodies: quo vadis?"},{"key":"10.4158\/EP-2019-0363_bb0175","first-page":"169","volume":"25","author":"Diana","year":"2015","journal-title":"Standardization of a bioassay for thyrotropin receptor stimulating autoantibodies"},{"key":"10.4158\/EP-2019-0363_bb0180","first-page":"192","volume":"139","author":"Leschik","year":"2013","journal-title":"Analytical performance and clinical utility of a bioassay for thyroid-stimulating immunoglobulins"},{"key":"10.4158\/EP-2019-0363_bb0185","first-page":"1159","volume":"39","author":"Diana","year":"2016","journal-title":"Highly variable sensitivity of five binding and two bioassays for TSH-receptor antibodies"},{"key":"10.4158\/EP-2019-0363_bb0190","first-page":"243","volume":"6","author":"Diana","year":"2017","journal-title":"Performance and specificity of 6 immunoassays for TSH receptor antibodies: a multicenter study"},{"key":"10.4158\/EP-2019-0363_bb0195","first-page":"2561","volume":"104","author":"Kahaly","year":"2019","journal-title":"High titers of thyrotropin receptor antibodies are associated with orbitopathy in patients with Graves disease"},{"key":"10.4158\/EP-2019-0363_bb0200","first-page":"341","volume":"51","author":"Allelein","year":"2019","journal-title":"Comparison of a bridge immunoassay with two bioassays for thyrotropin receptor antibody detection and differentiation"},{"key":"10.4158\/EP-2019-0363_bb0205","first-page":"1998","volume":"101","author":"Kahaly","year":"2016","journal-title":"Thyroid stimulating antibodies are highly prevalent in Hashimoto's thyroiditis and associated orbitopathy"},{"key":"10.4158\/EP-2019-0363_bb0210","first-page":"2279","volume":"118","author":"Ponto","year":"2011","journal-title":"Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy"},{"key":"10.4158\/EP-2019-0363_bb0215","first-page":"1382","volume":"71","author":"Tamaki","year":"1990","journal-title":"Low prevalence of thyrotropin receptor antibody in primary hypothyroidism in Japan"},{"key":"10.4158\/EP-2019-0363_bb0220","first-page":"4742","volume":"94","author":"Feingold","year":"2009","journal-title":"Prevalence and functional significance of thyrotropin receptor blocking antibodies in children and adolescents with chronic lymphocytic thyroiditis"},{"key":"10.4158\/EP-2019-0363_bb0225","first-page":"738","volume":"303","author":"Matsuura","year":"1980","journal-title":"Familial neonatal transient hypothyroidism due to maternal TSH-binding inhibitor immunoglobulins"},{"key":"10.4158\/EP-2019-0363_bb0230","first-page":"1147","volume":"81","author":"Brown","year":"1996","journal-title":"Incidence of transient congenital hypothyroidism due to maternal thyrotropin receptor-blocking antibodies in over one million babies"},{"key":"10.4158\/EP-2019-0363_bb0235","first-page":"625","volume":"22","author":"Downing","year":"2012","journal-title":"Severe maternal hypothyroidism corrected prior to the third trimester is associated with normal cognitive outcome in the offspring"},{"key":"10.4158\/EP-2019-0363_bb0240","first-page":"369","volume":"37","author":"Matsuura","year":"1990","journal-title":"Transient hypothyroidism in infants born to mothers with chronic thyroiditis--a nationwide study of twenty-three cases. The Transient Hypothyroidism Study Group"},{"key":"10.4158\/EP-2019-0363_bb0245","first-page":"404","volume":"73","author":"Evans","year":"2010","journal-title":"Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample"},{"key":"10.4158\/EP-2019-0363_bb0250","first-page":"126","volume":"362","author":"Sanders","year":"2003","journal-title":"Human monoclonal thyroid stimulating autoantibody"},{"key":"10.4158\/EP-2019-0363_bb0255","first-page":"645","volume":"66","author":"Fort","year":"1988","journal-title":"Neonatal thyroid disease: differential expression in three successive offspring"},{"key":"10.4158\/EP-2019-0363_bb0260","first-page":"14","volume":"23","author":"McLachlan","year":"2013","journal-title":"Thyrotropin-blocking autoantibodies and thyroid-stimulating autoantibodies: potential mechanisms involved in the pendulum swinging from hypothyroidism to hyperthyroidism or vice versa"},{"key":"10.4158\/EP-2019-0363_bb0265","first-page":"727","volume":"47","author":"Morshed","year":"2015","journal-title":"Graves' disease mechanisms: the role of stimulating, blocking, and cleavage region TSH receptor antibodies"},{"key":"10.4158\/EP-2019-0363_bb0270","first-page":"2123","volume":"95","author":"Lytton","year":"2010","journal-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy"},{"key":"10.4158\/EP-2019-0363_bb0275","first-page":"89","volume":"54","author":"Maugendre","year":"2001","journal-title":"Clinical value of a new TSH binding inihibitory activity assay using human TSH receptors in the follow-up of antithyroid drug treated Graves' disease. Comparison with thyroid stimulating antibody bioassay"},{"key":"10.4158\/EP-2019-0363_bb0280","first-page":"1175","volume":"9","author":"Khoo","year":"1999","journal-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy"},{"key":"10.4158\/EP-2019-0363_bb0285","first-page":"267","volume":"52","author":"Gerding","year":"2000","journal-title":"Association of thyrotrophin receptor antibodies with the clinical features of Graves' ophthalmopathy"},{"key":"10.4158\/EP-2019-0363_bb0290","first-page":"3464","volume":"91","author":"Eckstein","year":"2006","journal-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease"},{"key":"10.4158\/EP-2019-0363_bb0295","volume":"2015","author":"Kampmann","year":"2015","journal-title":"Thyroid stimulating but not blocking autoantibodies are highly prevalent in severe and active thyroid-associated orbitopathy: a prospective study"},{"key":"10.4158\/EP-2019-0363_bb0300","first-page":"600","volume":"60","author":"Goh","year":"2004","journal-title":"Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease"},{"key":"10.4158\/EP-2019-0363_bb0305","first-page":"809","volume":"10","author":"Noh","year":"2000","journal-title":"Thyroid-stimulating antibody is related to Graves' ophthalmopathy, but thyrotropin-binding inhibitor immunoglobulin is related to hyperthyroidism in patients with Graves' disease"},{"key":"10.4158\/EP-2019-0363_bb0310","first-page":"769","volume":"38","author":"Ponto","year":"2015","journal-title":"Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy"},{"key":"10.4158\/EP-2019-0363_bb0315","first-page":"489","volume":"87","author":"Hollowell","year":"2002","journal-title":"Serum TSH, T(4), and thyroid antibodies in the United States population (1988 to 1994): National Health and Nutrition Examination Survey (NHANES III)"},{"key":"10.4158\/EP-2019-0363_bb0320","first-page":"26","volume":"103","author":"Konishi","year":"1985","journal-title":"Primary myxedema with thyrotrophin-binding inhibitor immunoglobulins. Clinical and laboratory findings in 15 patients"},{"key":"10.4158\/EP-2019-0363_bb0325","first-page":"409","volume":"27","author":"Kraiem","year":"1987","journal-title":"Thyrotrophin receptor blocking antibodies: incidence, characterization and in-vitro synthesis"},{"key":"10.4158\/EP-2019-0363_bb0330","first-page":"211","volume":"36","author":"Kraiem","year":"1992","journal-title":"Changes in stimulating and blocking TSH receptor antibodies in a patient undergoing three cycles of transition from hypo to hyperthyroidism and back to hypothyroidism"},{"key":"10.4158\/EP-2019-0363_bb0335","first-page":"1123","volume":"51","author":"Tamai","year":"1980","journal-title":"Changes in thyroid function in euthyroid subjects with a family history of Graves' disease: a follow-up study of 69 patients"},{"key":"10.4158\/EP-2019-0363_bb0340","first-page":"687","volume":"33","author":"Takasu","year":"1990","journal-title":"Graves' disease following hypothyroidism due to Hashimoto's disease: studies of eight cases"},{"key":"10.4158\/EP-2019-0363_bb0345","first-page":"1081","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum"},{"key":"10.4158\/EP-2019-0363_bb0350","first-page":"315","volume":"27","author":"Alexander","year":"2017","journal-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum"},{"key":"10.4158\/EP-2019-0363_bb0355","first-page":"514","volume":"83","author":"Kung","year":"1998","journal-title":"A change from stimulatory to blocking antibody activity in Graves' disease during pregnancy"},{"key":"10.4158\/EP-2019-0363_bb0360","first-page":"3647","volume":"86","author":"Kung","year":"2001","journal-title":"Epitope mapping of tsh receptor-blocking antibodies in Graves' disease that appear during pregnancy"},{"key":"10.4158\/EP-2019-0363_bb0365","first-page":"6","volume":"102","author":"Kiefer","year":"2017","journal-title":"Fetal\/neonatal thyrotoxicosis in a newborn from a hypothyroid woman with Hashimoto thyroiditis"},{"key":"10.4158\/EP-2019-0363_bb0370","first-page":"1005","volume":"77","author":"Brown","year":"1993","journal-title":"Detection of thyrotropin binding inhibitory activity in neonatal blood spots"},{"key":"10.4158\/EP-2019-0363_bb0375","first-page":"155","volume":"2","author":"McKenzie","year":"1992","journal-title":"Fetal and neonatal hyperthyroidism and hypothyroidism due to maternal TSH receptor antibodies"},{"key":"10.4158\/EP-2019-0363_bb0380","first-page":"451","volume":"171","author":"Abeillon-du Payrat","year":"2014","journal-title":"Predictive value of maternal second-generation thyroid-binding inhibitory immunoglobulin assay for neonatal autoimmune hyperthyroidism"},{"key":"10.4158\/EP-2019-0363_bb0385","first-page":"S2","volume":"124","author":"Kahaly","year":"2011","journal-title":"Graves' disease: diagnostic and therapeutic challenges (multimedia activity)"},{"key":"10.4158\/EP-2019-0363_bb0390","first-page":"e1","volume":"18","author":"McKee","year":"2012","journal-title":"TSI assay utilization: impact on costs of Graves' hyperthyroidism diagnosis"},{"issue":"suppl 1","key":"10.4158\/EP-2019-0363_bb0395","first-page":"24","volume":"3","author":"Kahaly","year":"2014","journal-title":"Thyroid stimulating autoantibodies are clinically useful and predictive in Graves' disease"},{"key":"10.4158\/EP-2019-0363_bb0400","first-page":"390","volume":"173","author":"Li","year":"2013","journal-title":"A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity"},{"key":"10.4158\/EP-2019-0363_bb0405","first-page":"320","volume":"49","author":"Bossowski","year":"2016","journal-title":"Decreased proportions of CD4 + IL17+\/CD4 + CD25 + CD127- and CD4 + IL17+\/CD4 + CD25 + CD127 - FoxP3+ T cells in children with autoimmune thyroid diseases"}],"container-title":["Endocrine Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20350795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1530891X20350795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T22:09:04Z","timestamp":1761516544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1530891X20350795"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":80,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S1530891X20350795"],"URL":"https:\/\/doi.org\/10.4158\/ep-2019-0363","relation":{},"ISSN":["1530-891X"],"issn-type":[{"value":"1530-891X","type":"print"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TSH Receptor Antibodies: Relevance & Utility","name":"articletitle","label":"Article Title"},{"value":"Endocrine Practice","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.4158\/EP-2019-0363","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2020 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}